Yttrium-90 Ibritumomab Tiuxetan (Zevalin) With BEAM in Relapsed Low Grade B-Cell Lymphoma

This study has been completed.

Study NCT00138086 Information provided by Groupe d'Etudes de Lymphomes de L'Adulte

First Received: August 29, 2005 Last Updated: September 6, 2006 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	March 2009
Estimated Primary Completion Date:	No date given